Apremilast for Recalcitrant Cutaneous Dermatomyositis: A Review of Current Literature

Int J Dermatol. 2025 Apr 1. doi: 10.1111/ijd.17728. Online ahead of print.

Authors

Manjit Kaur¹, Jessica Kaffenberger¹, Judith Lin², Abraham M Korman¹

Affiliations

¹ Department of Dermatology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
² Division of Rheumatology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.

PMID: 40169526
DOI: 10.1111/ijd.17728

No abstract available

Keywords: PDE‐4 inhibitor; apremilast; dermatomyositis; treatment.

Publication types

Letter